Reaction Details |
| Report a problem with these data |
Target | HIV-1 protease |
---|
Ligand | BDBM468301 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Enzyme Inhibition of Purified HIV-1 Protease |
---|
IC50 | 17.3±n/a nM |
---|
Citation | Jude-Fishburn, CS; VanderVeen, LA; Riley, TA Protease inhibitors having enhanced features US Patent US10806794 Publication Date 10/20/2020 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
HIV-1 protease |
---|
Name: | HIV-1 protease |
Synonyms: | HIV-1 protease wild type |
Type: | Protein |
Mol. Mass.: | 10757.68 |
Organism: | Human immunodeficiency virus |
Description: | O90785 |
Residue: | 99 |
Sequence: | PQITLWQRPLVTVKIGGQLREALLDTGADDTVLEDINLPGKWKPKMIGGIGGFIKVKQYE
QVLIEICGKKAIGTVLVGPTPVNIIGRNMLTQIGCTLNF
|
|
|
BDBM468301 |
---|
n/a |
---|
Name | BDBM468301 |
Synonyms: | US10806794, Compound di-mPEG5-Atazanavir |
Type | Small organic molecule |
Emp. Form. | C58H92N6O17 |
Mol. Mass. | 1145.3811 |
SMILES | COCCOCCOCCOCCOCCOC(=O)N[C@@H](C(=O)NC(Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@H](NC(=O)OCCOCCOCCOCCOCCOC)C(C)(C)C)C(C)(C)C |r| |
Structure |
|